# GSK2239633 FTIH Study

> **NCT01371812** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 24 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** GSK2239633
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01371812
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03-29
- **Primary completion:** 2011-07-01
- **Final completion:** 2011-07-01
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2017-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01371812

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01371812, "GSK2239633 FTIH Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01371812. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*